Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 21 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Hep B vaccination coverage among adults in the USA

To accelerate Hep B elimination in the United States, public health programs should implement strategies to ensure that adults at high risk are offered Hep B vaccine, finds this week's Journal of the American Medical Association.

News image

fiogf49gjkf04

Hepatitis B virus infection is a major cause of cirrhosis and liver cancer in the United States.

The Advisory Committee on Immunization Practices has recommended a comprehensive strategy to eliminate Hepatitis B transmission.

This includes the prevention of perinatal Hepatitis B transmission, and universal vaccination of infants.

The strategy also includes catch-up vaccination of unvaccinated children, and vaccination of unvaccinated adults at increased risk for infection.

During 2004, 35% of adults aged 18 to 49 years received Hep B vaccine
Journal of the American Medical Association

The incidence of acute Hepatitis B has declined by 75%, from 9 per 100,000 population in 1990 to 2 per 100,000 population in 2004.

The greatest declines were among children and adolescents.

Incidence remains highest among adults, who accounted for approximately 95% of the estimated 60,000 new infections in 2004.

Dr Weinbaum and colleagues analyzed data from the 2004 National Health Interview Survey to measure Hepatitis B vaccination among adults.

The National Health Interview Survey is a multipurpose household health survey of a civilian of the United States, conducted by in-person interview.

The investigators estimated Hepatitis B vaccination coverage from self reports of sampled adults.

The analysis was restricted to adults aged 18 to 49 years, age groups that account for approximately 80% of adult Hepatitis B infections.

The investigators found that, during 2004, 35% of adults aged 18 to 49 years received Hepatitis B vaccine, including 45% of adults at high risk for Hepatitis B.

Hepatitis B vaccination also was associated with certain population characteristics, including female sex, and non-Hispanic ethnicity.

The team noted that higher educational achievement was also associated with Hepatitis B vaccination.

Persons with a routine source of health care, and with health insurance were more likely to report vaccination than those with no routine source of health care.

The same demographic and health-care use characteristics were associated with higher likelihood of vaccination among persons at high risk as among others.

In a multivariate model, after controlling for age, sex, education, occupation, and HIV test history, high risk remained a predictor of Hepatitis B vaccination.

Dr Weinbaum's team commented, “To accelerate elimination of Hepatitis B transmission in the United States, public health programs and clinical care providers should implement strategies to ensure that adults at high risk are offered Hepatitis B vaccine.”

JAMA 2006: 296(1): 33-4
06 July 2006

Go to top of page Email this page Email this page to a colleague

 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
Hep B in the Grey Zone
 15 May 2018 
New therapies for CDI
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 11 May 2018 
Depressive symptoms in IBD youth
 10 May 2018 
Post‐operative complications in elderly IBD
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 09 May 2018 
Esophageal dilatation in clinical practice 
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
PPI use and cognitive decline
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 30 April 2018 
Patient-reported outcome measures in IBD trials
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Fecal incontinence and quality of life in IBD
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Aspirin and pancreatic cancer
 25 April 2018 
Central mediators of irinotecan-induced steatohepatitis
 25 April 2018 
Neuroimaging in Hep C
 24 April 2018 
Scoring system identifies cancer risk in Barrett's
 24 April 2018 
Microbiome in athletes vs sedentary subjects
 24 April 2018 
PPI and risk of stroke
 23 April 2018 
Genome-wide study on HBV-related acute-on-chronic liver failure
 23 April 2018 
Antibody suitable for further clinical development to complement existing therapeutic strategies for HCV
 23 April 2018 
Sleep deprivation and NAFLD in the USA
 20 April 2018 
Two annexin A11 epitopes targeted by IgG1 and IgG4 autoantibodies were shared between patients with IAC/AIP and IgG4 antibodies blocked binding of IgG1 antibodies to the shared annexin A11 epitopes
 20 April 2018 
Adalimumab with azathioprine in Crohn's
 20 April 2018 
Worldwide H.pylori prevalence
 19 April 2018 
c-Myc expression and pancreatic cancer
 19 April 2018 
Olmesartan prescription in the USA

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us